Rb-379-928Δ738-775-pGex2T
(Plasmid
#21783)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 21783 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGex2T
-
Backbone manufacturerPharmacia
- Backbone size w/o insert (bp) 4948
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsDH5alpha BL21
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameRb
-
Alt nameretinoblastoma protein
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1556
-
Mutationdeletion mutant ORF contains aa 379-928D737-774 of wt Rb cDNA, contains deletion of aa 738-775 (equaling exon 22) contains mutation at codon 154 (full-length Rb aa I532T (ATC to ACC))
-
GenBank IDBC040540
-
Entrez GeneRB1 (a.k.a. OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb, pp110)
-
Tag
/ Fusion Protein
- GST (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH I (not destroyed)
- 3′ cloning site BamH I (not destroyed)
- 5′ sequencing primer pGex-5'
- 3′ sequencing primer pGex-3' (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Rb-379-928Δ738-775-pGex2T was a gift from William Kaelin (Addgene plasmid # 21783 ; http://n2t.net/addgene:21783 ; RRID:Addgene_21783) -
For your References section:
Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Kaelin WG, Pallas DC, DeCaprio JA, Kaye FJ, Livingston DM. Cell. 1991 Feb 8. 64(3):521-32. 10.1016/0092-8674(91)90236-R PubMed 1825028